Hayley A Hamilton1,2, Bruna Brands3,4,5, Anca R Ialomiteanu3, Robert E Mann3,6. 1. Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, 33 Russell St., Toronto, ON, M5S 2S1, Canada. hayley.hamilton@camh.ca. 2. Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada. hayley.hamilton@camh.ca. 3. Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, 33 Russell St., Toronto, ON, M5S 2S1, Canada. 4. Health Canada, Ottawa, ON, Canada. 5. Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada. 6. Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
Abstract
OBJECTIVE: To investigate the prevalence of therapeutic cannabis use within a general population sample of adults and to describe various characteristics associated with use. METHODS: Data were derived from the 2013 and 2014 CAMH Monitor Survey of adults in Ontario, Canada. This repeated cross-sectional survey employed a regionally stratified design and utilized computer-assisted telephone interviewing. Analyses were based on 401 respondents who reported using cannabis. RESULTS: The data indicated that 28.8% of those who used cannabis in the past year self-reported using cannabis for therapeutic purposes. Of therapeutic users, 15.2% reported having medical approval to use cannabis for therapeutic purposes. Cannabis use for therapeutic purposes was associated with more frequent use of cannabis, a moderate to high risk of problematic cannabis use, and a greater likelihood of using prescription opioids for medical purposes. There was little difference in cannabis use for therapeutic purposes according to sex, age, and marital status after adjusting for opioid use and problematic cannabis use. CONCLUSION: Findings suggest some potential negative consequences of cannabis use for therapeutic purposes; however, further research is needed to better understand the range and patterns of use and their corresponding vulnerabilities.
OBJECTIVE: To investigate the prevalence of therapeutic cannabis use within a general population sample of adults and to describe various characteristics associated with use. METHODS: Data were derived from the 2013 and 2014 CAMH Monitor Survey of adults in Ontario, Canada. This repeated cross-sectional survey employed a regionally stratified design and utilized computer-assisted telephone interviewing. Analyses were based on 401 respondents who reported using cannabis. RESULTS: The data indicated that 28.8% of those who used cannabis in the past year self-reported using cannabis for therapeutic purposes. Of therapeutic users, 15.2% reported having medical approval to use cannabis for therapeutic purposes. Cannabis use for therapeutic purposes was associated with more frequent use of cannabis, a moderate to high risk of problematic cannabis use, and a greater likelihood of using prescription opioids for medical purposes. There was little difference in cannabis use for therapeutic purposes according to sex, age, and marital status after adjusting for opioid use and problematic cannabis use. CONCLUSION: Findings suggest some potential negative consequences of cannabis use for therapeutic purposes; however, further research is needed to better understand the range and patterns of use and their corresponding vulnerabilities.
Authors: Penny F Whiting; Robert F Wolff; Sohan Deshpande; Marcello Di Nisio; Steven Duffy; Adrian V Hernandez; J Christiaan Keurentjes; Shona Lang; Kate Misso; Steve Ryder; Simone Schmidlkofer; Marie Westwood; Jos Kleijnen Journal: JAMA Date: 2015 Jun 23-30 Impact factor: 56.272
Authors: Peggy van der Pol; Nienke Liebregts; Ron de Graaf; Dirk J Korf; Wim van den Brink; Margriet van Laar Journal: Drug Alcohol Depend Date: 2013-07-22 Impact factor: 4.492
Authors: Brian J Piper; Rebecca M DeKeuster; Monica L Beals; Catherine M Cobb; Corey A Burchman; Leah Perkinson; Shayne T Lynn; Stephanie D Nichols; Alexander T Abess Journal: J Psychopharmacol Date: 2017-04-04 Impact factor: 4.153
Authors: Sanjeet Narang; Daniel Gibson; Ajay D Wasan; Edgar L Ross; Edward Michna; Srdjan S Nedeljkovic; Robert N Jamison Journal: J Pain Date: 2007-12-21 Impact factor: 5.820
Authors: Helen McTaggart-Cowan; Colene Bentley; Adam Raymakers; Rebecca Metcalfe; Philippa Hawley; Stuart Peacock Journal: Cancer Med Date: 2020-10-17 Impact factor: 4.452